Edition:
United Kingdom

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

26.17CNY
23 May 2018
Change (% chg)

¥0.18 (+0.69%)
Prev Close
¥25.99
Open
¥26.00
Day's High
¥26.87
Day's Low
¥25.96
Volume
17,864,435
Avg. Vol
12,410,492
52-wk High
¥29.25
52-wk Low
¥20.81

Chart for

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascula... (more)

Overall

Beta: 0.95
Market Cap(Mil.): ¥58,598.07
Shares Outstanding(Mil.): 2,688.91
Dividend: 0.36
Yield (%): 1.52

Financials

  601607.SS Industry Sector
P/E (TTM): 18.84 20.98 40.93
EPS (TTM): 1.26 -- --
ROI: 11.01 11.71 62.10
ROE: 10.70 13.91 73.67

BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Up 2.1 Percent Y/Y

April 27 Shanghai Pharmaceuticals Holding Co Ltd :

27 Apr 2018

BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Attributable RMB1.02 Billion

April 27 Shanghai Pharmaceuticals Holding Co Ltd :

27 Apr 2018

BRIEF-Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares

* Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017

26 Mar 2018

BRIEF-Shanghai Pharmaceuticals' 2017 Net Profit Up, To Issue Bonds, Debt Financing Instruments

March 23 Shanghai Pharmaceuticals Holding Co Ltd :

23 Mar 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products

05 Mar 2018

Shanghai Pharmaceuticals plans $400 mln share sale to fund production

HONG KONG, Jan 19 Shanghai Pharmaceuticals Holding Co Ltd said on Friday it planned to sell HK$3.13 billion ($400 million) worth of new shares to fund the development of its manufacturing and distribution businesses.

19 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​

* ‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​

19 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

10 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug

05 Jan 2018

Earnings vs. Estimates